Jeni Newman
Senior Director, Operation at NMDP BioTherapies

Jeni Newman began her career at NMDP 15 years ago as a search coordinator. Today, she serves as the senior director of operations at NMDP BioTherapies, where she leads the supply chain (logistics and case management); donor (donor screening and workup); network (onboarding and expertise associated with apheresis); process documentation and improvement, and vendor teams . She and her teams are dedicated to flawless delivery of services for cell and gene therapy developers.

Prior to her current role, Newman held leadership positions in the NMDP parent organization as a leader in the donor contact teams, director of case management and senior director of operational excellence, where she most recently provided strategic direction and leadership to a group that maintained relationships with more than 140 domestic transplant centers and led the relationship with 80 international partners. Growing that team to support increasing volumes while strategically changing how they supported the NMDP vision, she delivered a 98% satisfaction rating with customers. During the COVID-19 pandemic, Newman led many operational initiatives while maintaining global operations. Additionally, Newman led the deployment of new functionality for NMDP customers, increasing customer satisfaction with the application from 70% to 97% in five years. 

Log in to read the full article.

This article is reserved for AABB members.
Please log in or join AABB to continue reading.

White Coats

July 2026

July 2026 View Issue


Find More News

transfusion journal

Transfusion Journal

Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.

Learn More About Transfusion Journal
CellSource

AN UPDATE ON THE LATEST BIOTHERAPIES NEWS

Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.

Read and Subscribe Today

CONTACT US

To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.

CONNECT WITH US

AABB News

President

Jose Cancelas, MD, PhD, CABP

Chief Executive Officer

Debra Ben Avram, FASAE, CAE

Chief Communications and Engagement Officer

Julia Zimmerman

Director of Marketing and Communications

Jay Lewis, MPH

Managing Editor

Kendra Y. Mims, MFA

Senior Communications Manager

Drew Case

AABB News

(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.

AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.

+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.

Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.

2025 APEX Awards for Publication Excellence